Home Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
Article
Licensed
Unlicensed Requires Authentication

Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection

  • Shimin Wu , Xin Zhou , Huafen Yang , Jidong Yin , Chunlin Cai and Fang Zheng
Published/Copyright: February 1, 2009

Abstract

Background: Infections with hepatitis B virus (HBV) may lead to a distinct clinical outcome which is partially related to host genetic variability. Our aim was to investigate the relationships between the polymorphisms of the E-selectin gene and disease progression in a HBV-infected Chinese Han population, and also to determine the plasma soluble E-selectin (sE-selectin) levels in this population.

Methods: Genomic DNA was extracted from the peripheral blood of 367 HBV carriers and 281 healthy controls. Two polymorphisms (PstI for A561C and HphI for G98T) of the E-selectin gene were analyzed by polymerase chain reaction-restriction fragment length polymorphism. Circulating sE-selectin levels were measured by specific enzyme-linked immunosorbent assay (ELISA).

Results: The frequency of the C allele (AC or CC) of the A561C polymorphism was significantly higher in patients with liver cirrhosis (LC) compared to controls (p=0.002). There was no difference in allele distribution of the G98T polymorphism. But in patients with LC, classified according to the Child-Pugh classification, the frequency of the T carrier (GT and TT) was significantly different between Child-Pugh class A and class B plus C (p=0.009). Levels of plasma soluble E-selectin (sE-selectin) were significantly increased in HBV carriers with chronic hepatitis (CH) and LC (mean±SD 68.94±34.09 and 43.39±18.00 ng/mL) compared to controls (13.96±7.50 ng/mL) (p<0.01). In the LC subgroup, levels of sE-selectin were significantly decreased from Child-Pugh class A to class C (p<0.05). In each group, individuals with the C allele showed higher sE-selectin levels than those with the A allele (p<0.05).

Conclusions: This is the first report describing the association between E-selectin polymorphisms and HBV-related chronic liver diseases. Our data suggest that the A561C polymorphism of the E-selectin gene may be associated with disease progression in patients with chronic HBV infection and control the expression of plasma soluble levels, while the G98T polymorphism may be related to fibrotic severity in the Chinese population.

Clin Chem Lab Med 2009;47:159–64.


Corresponding author: Prof. Xin Zhou, Center for Gene Diagnosis, Zhongnan Hospital, Wuhan University, Wuhan 430071, China Phone: +86-27-62336678, Fax: +86-27-85776842,

Received: 2008-7-25
Accepted: 2008-10-29
Published Online: 2009-02-01
Published in Print: 2009-02-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
  3. Reviews
  4. Vitamin D: current status and perspectives
  5. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
  6. New European guidelines for cardiovascular disease prevention in clinical practice
  7. Review
  8. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
  9. Genetics and Molecular Diagnostics
  10. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
  11. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
  12. General Clinical Chemistry and Laboratory Medicine
  13. Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
  14. Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
  15. Methodology for monitoring cytomegalovirus infection after renal transplantation
  16. High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
  17. Reference Values and Biological Variations
  18. Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
  19. Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
  20. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
  21. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
  22. Validation and Outcome Studies
  23. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
  24. Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
  25. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
  26. Letters to the Editor
  27. Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
  28. Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
  29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.035/html
Scroll to top button